Latest news
Design Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 11:59:52 GMTIGR Stock Price and Chart — LSE:IGR - TradingViewTradingView · Tue, 04 Aug 2026 06:14:08 GMTDesign Therapeutics, Inc. 2Q 2026: Net loss $(20,165)K, EPS $(0.32) — 10-Q Summary - TradingViewTradingView · Mon, 03 Aug 2026 12:11:01 GMTDSGN: Positive RESTORE-FA data and strong cash position support ongoing clinical progress - TradingViewTradingView · Mon, 03 Aug 2026 12:10:22 GMTDSGN: Positive FA clinical data, strong liquidity, and ongoing pipeline progress amid rising expenses - TradingViewTradingView · Mon, 03 Aug 2026 12:08:54 GMTWeekly Recap: H1 2026 results and Israeli defense design contract - TradingViewTradingView · Mon, 03 Aug 2026 11:33:04 GMTDSGN Q2'26 Earnings: revenue estimate is 0 USD - TradingViewTradingView · Mon, 03 Aug 2026 11:00:17 GMTCADENCE DESIGN SYSTEMS INC 2026: Revenue $1.58B, EPS $1.33— 10-Q Summary - TradingViewTradingView · Wed, 29 Jul 2026 07:00:00 GMT